50 results about "Treatment duration" patented technology

The invention provides a quadruple plasma blood purification device and purification method. The quadruple plasma blood purification device comprises a primary plasma separator, a secondary plasma separator, a perfusion device and a dialyzer, the inlet of the primary plasma separator is connected with the artery of a patient; an inlet of the secondary plasma separator is connected with the primary plasma separator; an inlet of the perfusion device is connected with the secondary plasma separator; and the dialyzer is respectively connected with the perfusion device and the primary plasma separator. According to the technology, only one-time operation is needed for treatment for 6-12 hours, multiple operations are not needed, meanwhile, the core pathogenesis of hypertriglyceridemia, cytokine storm sepsis, internal environment disorder and renal insufficiency which cause pancreatitis is solved, the treatment time is saved to a great extent, the risk that the illness state develops to death is reduced, and the treatment cost is reduced. The clinical effective treatment rate is improved; in addition, only one set of equipment is needed, and the device has the advantages of low cost, simplicity and convenience in operation, low time, manpower and financial resource consumption, high treatment efficiency and the like.

The invention discloses a schizophrenia patient medication compliance evaluation electronic system based on big data, and relates to the technical field of evaluation.The schizophrenia patient medication compliance evaluation electronic system comprises a data monitoring module, a data analysis module, a treatment adjustment module and a database, and is characterized in that the heart rate, blood pressure and body feedback of each patient after each time of medication in each treatment time period are detected; the method comprises the following steps: analyzing the medication compliance coefficient and the body feedback condition of each patient according to the treatment time of each patient, the blood concentration and the disease recovery score of each patient by a doctor, judging whether each patient needs to adjust the used medicine in each treatment time period, and after each treatment time period of each patient in a hospital is finished, judging whether the patient needs to adjust the used medicine. Whether each patient can go home for treatment or not is judged according to the medication compliance coefficient of each patient in each treatment time period, the illness state recovery score and the historical illness condition after each time of going home, the illness state stability of the patient after going home for treatment is guaranteed, and the accuracy of medication compliance coefficient analysis of the patient and the effectiveness of medication treatment are guaranteed.

The present invention relates to the technical field of aromatherapy in traditional Chinese medicine, and specifically to an aromatherapy composition for treating peripheral phlebitis through transdermal absorption, and its preparation and application. The aromatherapy composition and its preparation of the present invention are used for transdermal treatment of peripheral superficial phlebitis through aromatherapy in traditional Chinese medicine, and the overall effective rate of 24h treatment is 100%, of which the cure rate is 55%, and the cure rate is 97.5% after 48h. The reduction of phlebitis grade is recorded as grade difference, and the sum of grade differences of 40 patients is 125. The treatment effect of peripheral superficial phlebitis is significantly superior to traditional and commonly used methods. Compared with traditional therapies, it can greatly shorten the treatment time, quickly relieve pain, reduce the incidence of complications, and has stable and reliable efficacy. Patients' compliance, comfort and acceptability during the treatment process are very good.

The main and collateral channel moxibustion device comprises a shell, a positioning sliding rod penetrates through a first through groove formed in the shell, the positioning sliding rod is limited in the shell through a limiting stopper, the bottom of the positioning sliding rod is fixedly connected with a medicine containing chamber, and a plurality of sets of outer auxiliary needles are annularly arranged at the bottom of the medicine containing chamber; a moxibustion needle is further arranged at the position, located on the inner side of the outer auxiliary needle, of the bottom of the medicine containing chamber, a connecting ring block is extruded through a pressure spring, and after pressing on a positioning sliding rod is manually released, the positioning sliding rod can be rapidly reset so as to better protect the moxibustion needle and the outer auxiliary needle; the sliding block slides in the sliding groove so that rotation of the positioning sliding rod can be limited when the positioning sliding rod slides, the hot fumigation effect can be concentrated through the outer auxiliary needle, the hot fumigation effect can be better guided into meridians and collaterals, the treatment duration is shortened, after the sliding block penetrates into the positioning ring groove, the lantern ring is rotated so that the sliding block can be limited by the positioning ring groove, and the treatment effect is improved. After the pressing positioning sliding rod is loosened, the positions, away from the affected part, of the moxibustion needle and the outer auxiliary needle are positioned.

Dialysis device for performing peritoneal dialysis with at least one control unit, with at least one input unit for inputting one or more values, and with at least one processor, wherein the processor is designed to perform a method for estimating the treatment duration of a peritoneal dialysis treatment, wherein the estimation of the treatment duration is based on an ideal treatment duration, wherein the ideal treatment duration is increased by one or more delay values, characterized in that the delay values ​​depend on one or more patient-specific parameters.where a patient-specific parameter is catheter performance and the catheter performance is taken into account when estimating the infusion time and / or when estimating the outflow time and / or when estimating the duration of the last infusion, and the catheter performance, and in particular an absolute or relative increase thereof, is editable by a user.

The utility model provides a stoma enema instrument, which belongs to the technical field of medical instruments, and comprises an outer fixing sleeve, a protective component, an inner fixing sleeve and a fixing component, the outer wall of the outer fixing sleeve is fixedly connected with uniformly distributed sliding frames, and the protective component comprises a contact sleeve slidably connected to the outer walls of the sliding frames. The outer wall of the contact sleeve is fixedly connected with telescopic rods which are evenly distributed, the telescopic rods are fixedly connected with the outer fixing sleeve, and the outer walls of the telescopic rods are sleeved with strong springs. According to the drainage tube fixing device, the position can be freely adjusted through the arranged clamping plates, drainage tubes with different thicknesses can be clamped and fixed, installation and fixing of the drainage tubes with different tube diameters can be easily and rapidly completed without frequently replacing equipment or using additional auxiliary tools, operation convenience and efficiency are greatly improved, and the drainage tube fixing device is convenient to use and high in practicability. An enema system can be conveniently and rapidly built in an emergency, precious treatment time is won for a patient, and the medical cost is reduced.

The present invention discloses a regional integrated emergency stroke unit, which relates to the medical field. The regional integrated emergency stroke unit includes an information interaction area, an imaging examination area and a thrombolytic therapy area; wherein the information interaction area is provided with a doctor's workstation, a comprehensive information monitoring display and a process support AI assistant; the imaging examination area is provided with detection equipment, a first TV display screen, a low-field movable magnetic resonance imaging device and an AI-assisted decision-making system; the process support AI assistant performs automatic consultation and auxiliary neurological scale scoring through voice interaction or touch screen typing interaction, and also provides retrieval support for real-time knowledge base and clinical guidelines; the AI-assisted decision-making system assists in decision-making based on the automatic consultation results, scale scoring results, test results and head and neck magnetic resonance imaging results, generates and displays a treatment plan. The present invention concentrates all diagnosis and treatment activities involved in acute ischemic stroke patients after they arrive at the hospital into one space, which can significantly shorten the time for diagnosis and treatment.

The invention provides an integral femoral artery cannula plugging device after ECMO machine removal, which comprises a main tube, a connecting mechanism, a drainage tube, a drainage tube, a drainage tube and a drainage tube, and is characterized in that the main tube is movably mounted in a femoral artery cannula through the connecting mechanism; the connecting mechanism comprises a bag body and a connecting hose, and the bag body is installed outside the main pipe; one end of the connecting hose is connected with the bag body, a valve is arranged at the other end of the connecting hose, expansion or contraction of the bag body is controlled by injecting or releasing a medium into the bag body, and plugging or opening of the femoral artery cannula is achieved. Blocking and opening of the cannula are achieved through expansion / contraction of the bag body, complexity of cannula treatment after traditional machine removal is avoided, the cannula can be directly used when the cannula is used on a machine again, and key treatment time is saved; the double-cavity structure can achieve tube washing and tube sealing respectively, and the risk of thrombus formation is effectively reduced; the probability that external pollutants enter can be reduced through bag body plugging and cock auxiliary sealing, and the infection risk is reduced.

An apparatus for locating and venting pathogen cells in blood. A cassette has a plurality of thin holding chambers that are filled with blood drawn from a patient. A light source illuminates each of the holding chambers and passes light to an underlying sensor array such that the cells in the blood produce shadow images of the cells in the sensor array. A processor performs pattern recognition to identify and locate the pathogen cells by use of an image library. After the pathogen cells are located, a pump is operated to move the identified cells to a processing zone. When each identified cell reaches the processing zone, a control voltage is generated to open a valve to vent the identified pathogen cells. The pump refills the cassette holding chambers, returns the processed blood to the patient, and the procedure is repeated for a treatment time period.

The invention relates to the technical field of medical instruments, and mainly discloses a double-balloon dilatation guiding rapid trachea device and a using method thereof.The double-balloon dilatation guiding rapid trachea device comprises a trachea cannula and an incision device assembly which are used in cooperation, and the incision device assembly comprises a puncture body and a guide-in hose connected with the rear end of an incision device; the leading-in hose is provided with a first balloon and a second balloon which are tightly arranged front and back, and the first balloon and the second balloon are both connected with overflowing hoses. By arranging the incision device assembly and the trachea cannula, the operation difficulty of operators is reduced, the efficiency of tracheotomy operation is improved, more treatment time is won for patients, the first balloon abuts against the inner wall of the annular cartilage of the trachea of the patient, and the probability that the first balloon abuts against the inner wall of the annular cartilage of the trachea of the patient in the artificial airway expansion process is reduced; the medical risks that the tracheal ring is pressed to collapse or break, the cartilage is inwards rolled and exposed out of the tracheal cavity, granuloma is formed, and tube drawing is difficult are further improved, and the medical safety guarantee is further improved.

The invention belongs to the technical field of medical data processing, and provides a multimodal fusion-based liver cancer longitudinal relapse prediction and treatment effect evaluation system, which comprises a data set construction module, which is used for forming a longitudinal queue data set by using longitudinal queue data samples of a plurality of patients, and setting a relapse time label for each longitudinal queue data sample; the training module is used for training a recurrence network by utilizing the longitudinal queue data set to obtain a recurrence model; the recurrence prediction module inputs the to-be-predicted longitudinal queue data of the patient into the recurrence model to obtain a prediction result of each treatment time point, and the prediction result comprises the recurrence probability of more than one future time period; the curative effect evaluation module is used for acquiring simulation longitudinal queue data corresponding to different treatment modes selected by the to-be-evaluated patient at the current relapse time point; and inputting the simulated longitudinal queue data into the recurrence model to obtain a prediction result of each treatment time point. According to the method, the accuracy and generalization of the recurrence model are improved, and doctors are accurately and efficiently assisted in selecting treatment modes.

The invention discloses an intelligent reservation number calling system and a method thereof, and belongs to the technical field of medical information. The system comprises a data acquisition module, an intelligent estimation module, a resource collaborative scheduling module and a patient service module. By collecting static and dynamic treatment data of a patient, personalized dynamic estimation of the treatment duration is realized; generating an optimized daily scheduling plan based on multi-dimensional constraints such as mold type collaboration, equipment load and human state; and the queuing information and the equipment state are pushed to the patient in real time. According to the invention, the problems of uncertain treatment duration, non-cooperative resource scheduling and non-transparent information of the radiotherapy center are solved, and comprehensive improvement of accurate reservation, efficient scheduling and patient experience is realized.

Devices, systems, and methods for localized delivery of a chemotherapy, hormonal therapy, or targeted drug / biologic therapy to a target tissue area of an internal body organ of a patient. Computer systems may be used for planning and navigation in super selective drug delivery via a tracheobronchial airway. A catheter may be used to form a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin to saturate the target tissue area. The chamber is evacuated at the end of the treatment session.

The utility model discloses a quick binding and fixing device for intestinal bulge, which relates to the field of medical instruments and comprises a protective band, a hollow base and a transparent bowl, a main binding band and an auxiliary binding band are respectively sewed on two sides of the protective band, and the main binding band and the auxiliary binding band are connected to fix the protective band on the abdomen of a patient; a reserved hole is formed in the middle of the protective belt, and the hollow base is installed in the reserved hole. According to the utility model, the transparent bowl is buckled on the bulged intestinal part, and the main bridle is connected with the auxiliary bridle, so that the protective band and the transparent bowl are quickly fixed, and the wounded can observe the bleeding and blood circulation conditions of the bulged part at any time through the transparent bowl in the transfer process; if bleeding, necrosis and the like occur in the transferring process, the transparent bowl can be detached at any time for treatment and treatment, the optimal treatment time is grasped, the wound treatment time is shortened, and the wounded can be treated and cured in time.

The invention relates to the technical field of gynecological tumors, and discloses a gynecological tumor disease risk intelligent prediction system which comprises a data acquisition module, a data storage module, a data analysis module, a feature extraction module, a model training module, a risk prediction module and a result display and feedback module. According to the intelligent risk prediction system for the gynecological tumor diseases, the data related to the gynecological tumor diseases are rapidly extracted through the data analysis module and the feature extraction module by adopting the clinical symptoms, family medical history, living habits, various examination indexes and other multi-dimensional data of patients, and the data related to the normal range numerical values are compared in a brush year; by means of the method, potential risk signals can be accurately captured when obvious clinical symptoms or signs do not appear in the early stage of the disease, by increasing associated data, the discovery rate of early tumor diseases is increased, precious treatment time is won for patients, and the healing possibility and the prognosis effect are greatly improved.

To provide a suitable method and system for consistent, prepareable, and safe cryospray treatment of airway tissue. [Solution] A method and system for automated and semi-automated, predictable, consistent, safe, effective, lumen-specific, and patient-specific cryospray treatment of airway tissue, wherein, following input of patient information and treatment location information by the user into the system, the treatment duration is automatically set by the system, and the treatment spray is automatically stopped by the system when the automatically selected treatment duration is achieved as determined by the system.

The invention discloses a physiotherapy equipment tail end contact medium identification method based on impact rheological characteristics. Compared with the prior art, the method has the advantages that identification accuracy and cheating prevention are improved, the defect that treatment time is also calculated when a traditional current method is pressed on a table is overcome, and the algorithm can be confirmed to be effective only when the method is really pressed on biological tissue with viscoelasticity; hardware cost is reduced, a pure software algorithm is adopted, a pressure sensor or a distance sensor does not need to be added, and large-scale mass production is facilitated; and safety protection: abnormal oscillation on bones can be recognized in milliseconds, and bone contusion of old people or rehabilitation patients is prevented.

The present application relates to the field of medicine, and discloses an integrated emergency stroke unit having regions. The integrated emergency stroke unit having regions comprises an information interaction area, an imaging examination area, and a thrombolysis treatment area. The information interaction area is provided with a doctor workstation, a comprehensive information monitoring display, and a process-support AI assistant. The imaging examination area is provided with a detection device, a first television display screen, a low-field movable magnetic resonance imager, and an AI-assisted decision-making system. The process-support AI assistant performs automated consultation and assists in nervous system scale scoring by means of voice interaction or touch screen input interaction, and also provides retrieval support for a real-time knowledge base and clinical guidelines. The AI-assisted decision-making system assists in decision-making on the basis of an automated consultation result, a scale scoring result, a detection result, and a head and neck magnetic resonance imaging result, generates a treatment plan, and displays the treatment plan. According to the present application, all diagnosis and treatment activities involved upon the arrival of a patient suffering from acute ischemic stroke at a hospital are integrated into a single space, which can significantly shorten diagnosis and treatment time.

The present application relates to the technical fields of ankle treatment, and specifically discloses a physiotherapy device for preventing and treating ankle injury, which comprises an ankle guard cover, two sides of the ankle guard cover are provided with mounting covers, a microwave treatment assembly is arranged inside the mounting cover, the microwave treatment assembly comprises a treatment head one arranged at the center of the mounting cover, an outer ring of the treatment head one is provided with a treatment ring one, a surface of the treatment ring one is connected with a treatment ring two through a connecting plate one, and an outer ring of the treatment ring one is provided with a treatment head two, a connecting assembly one and a driving assembly, the connecting assembly one is arranged at the side of the microwave treatment assembly, the driving assembly is arranged at the end face of the connecting assembly one, the connecting assembly one is moved through the driving assembly, and the swelling degree of the ankle part of a patient is monitored through the connecting assembly one; the most suitable microwave power and treatment time can be provided in real time according to the swelling degree of the ankle, treatment is more suitable for the changes of the patient's condition, and better treatment effect is achieved.

The invention provides a self-adaptive radiotherapy assessment method and device and a storage medium, and relates to the technical field of radiotherapy. The method comprises the following steps: acquiring a real-time image of a target volume, wherein the target volume comprises a target region and / or an organ at risk; determining the contour of the deformed target volume based on the real-time image of the target volume and the planned reference image of the target volume, and performing dose calculation based on the contour of the deformed target volume and the first dose parameter to obtain a second dose parameter matched with the deformed target volume; the first dose parameter is a dose parameter for making a treatment plan for a target volume in the planned reference image; and determining that the second dose parameter meets the dose evaluation requirement, and indicating that adaptive radiotherapy does not need to be performed on the target volume. According to the invention, whether self-adaptive radiotherapy needs to be carried out can be evaluated and indicated, so that unnecessary resources are prevented from being consumed, and the workload of medical personnel and the treatment duration of a patient are reduced.

The invention discloses a medicine tank which comprises a medicine tank body, an electrode plate and an air pump, the electrode plate is provided with a first bonding layer bonded with the skin of a patient, the upper surface of the electrode plate is provided with a second bonding layer used for bonding the medicine tank body, and the electrode plate is provided with a plurality of ventilation holes used for ventilation; the medicine tank body is provided with a ventilation column, and the ventilation column is communicated with the air pump. The medicine tank is reasonable in design, medicine tank therapy and electric physiotherapy therapy can be carried out at the same time, the treatment duration of a patient is shortened, and the patient experience is improved.

The utility model belongs to the technical field of medical nursing tools, and particularly relates to a drainage and enema dual-purpose excrement collecting device which comprises a tube body, a first pressure detection mechanism, a second pressure detection mechanism and a fixing mechanism. The pipe body comprises an outer pipe, a middle pipe, a first inner pipe and a second inner pipe, the left ends of the outer pipe, the middle pipe, the first inner pipe and the second inner pipe are head parts, and the right ends of the outer pipe, the middle pipe, the first inner pipe and the second inner pipe are tail parts; an end cover is arranged at the other end of the outer pipe; the periphery of the outer tube is sleeved with a first air bag and a second air bag, the first air bag and the second air bag are each of an annular structure, and the first air bag and the second air bag are sequentially distributed on the periphery of the outer tube from left to right. By adopting the double-air-bag design, the drainage device can be effectively and internally fixed, meanwhile, the drainage structure and the enema structure are arranged, two operations of drainage and enema can be achieved, the structure is simple and convenient, use is convenient, the enema efficiency is improved, the treatment time of a patient is shortened, and the pain of the patient is reduced.

The present application belongs to the technical field of medical data processing, and provides a liver cancer longitudinal recurrence prediction and treatment efficacy evaluation system based on multi-modal fusion, comprising: a data set construction module, which uses multiple patient longitudinal cohort data samples to form a longitudinal cohort data set, and sets a recurrence time label for each longitudinal cohort data sample; a training module, which trains a recurrence network using the longitudinal cohort data set to obtain a recurrence model; a recurrence prediction module, which inputs the patient's to-be-predicted longitudinal cohort data into the recurrence model to obtain prediction results at each treatment time point, the prediction results including the recurrence probability of more than one future time period; and an efficacy evaluation module, which obtains simulated longitudinal cohort data corresponding to different treatment methods at the current recurrence time point of the patient to be evaluated; and inputs the simulated longitudinal cohort data into the recurrence model to obtain prediction results at each treatment time point. The present application improves the accuracy and generalizability of the recurrence model, and accurately and efficiently assists doctors in selecting treatment methods.

The utility model relates to the technical field of diabetic foot treatment, and particularly discloses a diabetic foot debridement device which comprises a box body, a foot placing table is arranged in the box body, the upper end face of the foot placing table is fixedly connected with a plurality of evenly-distributed toe separation supporting blocks, and the upper end of the interior of the box body is slidably connected with a movable plate. A first cavity and a second cavity which are distributed up and down are formed in the movable plate, a plurality of water spray nozzles which are uniformly distributed and communicate with the first cavity are fixedly connected to the lower end face of the movable plate, the air heater conveys hot air into the second cavity through a first pipeline, and then the hot air is sprayed out through the multiple air spray nozzles; water stains remaining on the outer wall of the foot are removed through hot air, then the treated foot is bound, then the water stains remaining on the foot are rapidly removed, the treatment time is effectively shortened, the foot does not need to be exposed in air for a long time, the wound surface is prevented from being polluted by environmental microorganisms, and the condition of a patient is prevented from being aggravated due to secondary infection.

The invention relates to the technical field of multi-modal magnetic resonance detection, and discloses a cerebral arterial thrombosis multi-modal magnetic resonance image difference detection method, which comprises the following steps: acquiring a multi-modal magnetic resonance image, forming an image set, forming difference data, acquiring a difference database, acquiring life data of a target patient, forming disease analysis data, and forming an evaluation result. According to the cerebral arterial thrombosis multi-mode magnetic resonance image difference detection method, difference data are automatically judged, genetic disease history, past medical history, dietary habits and sleep habits of a patient are automatically obtained, corresponding possible diseases of the patient are judged, each possible disease of the patient is automatically evaluated, and a detection evaluation report is generated. According to the method, the condition of missed diagnosis is avoided, the condition of misjudgment caused by the fact that living habits of the patient and data such as past medical history cannot be combined is avoided, the waiting and treatment time of the patient is shortened, and the doctor-patient contradiction caused by many examination items and high examination cost is reduced.

An information display and control system that enables a fast and easy understanding and management of the status of the patient's dialysis is disclosed. Also disclosed is an information display and control system that enables a fast and easy understanding and management of the status of the patient's cardiovascular and ventilation systems. The system can control management of a patient's dialysis, as well as administration and management of a patient's medication and fluids. The display is organized by goals related to management of patient's dialysis machine, blood flow, dialyzer flow, and patient's body weight. The display is also organized by goals related to management of patient's cardiovascular system, ventilation system, and medications and fluids administration and management. Such goals include urea reduction rate, urea reduction ratio, fractional urea clearance, total urea reduction, dialysis treatment duration, hemodynamics, oxygenation, CO2 removal, medication status, and fluids status.

Systems and methods for monitoring and managing neurological diseases and conditions are disclosed herein. In some embodiments, a method for monitoring a patient having a neurological disease or condition includes receiving, from one or more patient monitoring devices, first patient data for a baseline time period. The method can include determining, based on the first patient data, first seizure data and first side effect data during the baseline time period. The method can further include receiving, from the one or more patient monitoring devices, second patient data for a treatment time period, and determining, based on the second patient data, second seizure data and second side effect data during the treatment time period. The method can also include generating a personalized dose-response profile for the patient based on the first and second seizure data and the first and second side effect data.

The application relates to the field of biological medicine, and particularly discloses a fusion protein and application thereof. The fusion protein is composed of a polypeptide and six histidines, the polypeptide has sequence consistency of at least 9 / 10, 14 / 15 or 29 / 30 with the amino acid sequence shown in SEQ ID NO:1, and the six histidines are located at the C-terminal of the polypeptide. The fusion protein designed in the application is derived from a human body protein, the metabolic product is an amino acid, and therefore the safety is better than that of other therapeutic drugs. Moreover, the fusion protein can significantly reduce the infarction volume of the brain of a tMCAO model mouse, has a significant treatment on ischemic stroke, and has a longer treatment time window than that of an existing thrombolytic drug. Compared with the existing ischemic stroke treatment drug, the human sTREM2-6His fusion protein has a brand-new treatment mechanism and target.

The invention discloses a breast cancer postoperative automatic rehabilitation assisting method and related equipment. The method comprises the steps that a near-end physiological signal of a target patient is obtained, the near-end physiological signal is used for representing the liquid load or compliance state of near-end tissue, and the near-end tissue comprises at least one of anterior axillary line, subclavian, scapular region and chest wall; calculating a near-end fullness index of the target patient based on the near-end physiological signal; and under the condition that the near-end filling degree index does not reach a preset release threshold value, a pressurizing assembly is controlled to preferentially maintain or prolong the maintaining and emptying time interval of the near-end cavity, and starting of the far-end cavity is limited. The problem that in current clinical practice, part of medical institutions adopt a one-cut air pressure treatment scheme such as a fixed pressure gradient, a single inflation mode or a constant treatment duration, and the standardized operation neglects pathological differences among individual patients although the standardized operation is convenient to execute can be solved.

Described herein are compositions and methods for treating ischemic injury in a subject comprising administering a therapeutically effective amount of an acellular amniotic fluid (acAF) to an ischemic injury situs within a therapeutic time window.